Eli Lilly and Company vs AbbVie Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while AbbVie Inc. (ABBV) is "Tailwind" with +10.0% revenue growth. Both companies report in the Healthcare sector.
| Metric | Eli Lilly and Company (LLY) | AbbVie Inc. (ABBV) |
|---|---|---|
| Operator Signal | Tailwind | Tailwind |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $19.8B | $16.6B |
| Revenue Growth | 73.1%* | 10.0% |
| Latest EPS | $8.26* | $1.02 |
| EPS Growth | 672.0% | N/A |
| Sector | Healthcare | Healthcare |
| Quarters Tracked | 8 | 8 |
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while AbbVie Inc. (ABBV) is "Tailwind" with +10.0% revenue growth. Both companies report in the Healthcare sector.